ArticleCase reports in neurology

Neurological Immune-Related Adverse Events in Patients Treated with Anti-Programmed Death 1 Agent, Pembrolizumab: A Case Series.

Sepehr Khosravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.